Lurie Children’s use cookies to improve your experience on our website and to show you personalized content. To find out more, read our Website Privacy Policy. By using the site and clicking on "I AGREE", you accept to the use of Cookies.
Phase 1 Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma
Official Title:
Phase 1 Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma
This phase I trial studies the side effects and best dose of panobinostat in treating younger patients with diffuse intrinsic pontine glioma that is growing, spreading, or getting worse (progressive). Panobinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.